Models of preclinical Alzheimer's disease (AD) propose that cerebral amyloidosis leads to neurodegeneration and subsequent cognitive decline. This study investigated whether APOE genotype is related to β-amyloid (Aβ) burden in brain regions preferentially affected by AD and whether Aβ burden is associated with gray matter fraction (as a marker of neurodegeneration) and episodic memory performance in cognitively normal middle-aged individuals at varying genetic risk for AD. Three groups of cognitively normal participants aged 50-65 with a firstdegree family history of AD [APOE genotype ε4ε4 (n=15), ε3ε4 (n=15), and ε3ε3 (n=15)],
Introduction
In recent years, Alzheimer's disease (AD) has been conceptualized as a continuum of disease, beginning with a preclinical stage in which symptoms are not yet present (Sperling et al., 2011) .
The preclinical stage is postulated to involve accumulating brain pathology followed by very subtle cognitive decline. This stage may precede Mild Cognitive Impairment (MCI) by several years and represents an important stage for early intervention and symptom prevention.
Most research in preclinical AD and prevention has focused on the 65+ population. The study of this older age group offers a high likelihood of capturing cases of preclinical AD, as the percentage of individuals with cerebral β-amyloid (Aβ) pathology increases from about 20% at age 65 to about 40% at age 85 (Jansen et al., 2015) . AD prevention studies are already targeting this age group, which confers greater practical power to test treatments (Sperling et al., 2014) .
Work to operationalize the new NIA-Alzheimer's Association diagnostic criteria has thus largely focused on adults over 65 years of age (Jack et al., 2012) . Moreover, convergent evidence suggests that elderly individuals with brain Aβ accumulation demonstrate subtle cortical thinning (Dickerson et al., 2009) , greater rates of cortical and hippocampal atrophy (Andrews et al., 2013; Chetelat et al., 2012; Schott et al., 2010) , and disruption of functional connectivity (Hedden et al., 2009; Mormino et al., 2011; Sheline et al., 2010) . Finally, a number of studies have reported that individuals with elevated brain Aβ perform worse on neuropsychological tests (Hedden et al., 2012; Rentz et al., 2010; Rodrigue et al., 2012; Sperling et al., 2013) and are at increased risk for cognitive decline and progression to MCI and AD dementia (Ellis et al., 2013; Knopman et al., 2012; Lim et al., 2013b; . Mecca, A.P. et al p. 4 However, an equally important but comparatively neglected population is that of middle-aged (50-65) individuals with preclinical AD. This younger age group may present an earlier stage of disease pathogenesis and thus a greater opportunity for early intervention. Studies of preclinical AD in the 50-65-year-old population require the use of risk factors (family history and APOE ε4) to enrich samples for the presence of AD pathogenesis. Studies of cognitively normal individuals at high genetic risk of AD (i.e., APOE ε4 homozygotes and heterozygotes, compared to noncarriers, mean age 64 years) have reported that cortical fibrillar Aβ burden is significantly associated with APOE ε4 carrier status and APOE ε4 dose (Reiman et al., 2009) . In cognitively normal subjects enriched for parental family history and APOE ε4 enrolled in the Wisconsin Registry for AD Prevention (mean age 60-61 years) Aβ status has not been associated with lower GM volume (Johnson et al., 2014) , but has been linked to thinning of entorhinal cortex (Doherty et al., 2015) . Moreover, elevated brain Aβ has not been associated with cognition crosssectionally but confers an increased risk of MCI longitudinally and steeper rates of cognitive decline (Clark et al., 2016) .
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In the present study, our over-arching goal was to utilize a middle-aged sample that is highly enriched-both for family history and genetic risk of AD-to address three major hypotheses: 1) that APOE genotype was related to global fibrillar Aβ burden as measured by [
11 C]PiB) in cognitively normal first-degree relatives; 2) that fibrillar Aβ burden was associated with gray matter fraction (as a marker of neurodegeneration) in brain regions known to be preferentially affected by AD; and 3) that fibrillar Aβ burden was associated with episodic memory (and neuropsychological test) performance. The primary analyses were performed with partial volume M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT Mecca, A.P. et al p. 5 corrected (PVC) PET data, but we also studied the effect of PVC on the results.
Methods

Participants
Cognitively normal adults aged 50-65 with a positive family history for probable AD (in at least one first-degree relative) were invited to participate. (Folstein et al., 1975) , Clinical Dementia Rating Scale (CDR) (Morris, 1993) , Logical Memory II (Wechsler, 1987) , and the Geriatric Depression Scale.
Participants were excluded for possible or probable AD (McKhann et al., 1984) , or MCI (Petersen, 2004) [as evidenced by CDR>0 (Morris, 1993) and abnormal memory function documented by scoring 1.5 SD below education adjusted cutoff on Logical Memory II subscale from Wechsler Memory Scale -Revised (Wechsler, 1987) ], or has a score on MMSE (Folstein et al., 1975) <27. In addition, they were excluded for any significant neurologic disease, unstable 
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MRI Segmentation-Prior to transformation to MNI template space, MR images were
segmented into GM, WM, and CSF using FAST-FMRIB's Automated Segmentation Tool (The Analysis Group, FMRIB, Oxford, UK). To quantify cortical GM within each ROI while accounting for intersubject variability in brain size, we applied inverse transformations of the AAL from MNI to subject space and calculated GM fraction as the number of voxels segmenting as GM divided by the total number of voxels in a region. GM fractions (ranging between 0.00 and 1.00) were thus generated for the mean cortical ROI and component ROIs.
Partial Volume Correction (PVC)-Some studies of cognitively intact adults have shown
GM reduction in APOE carriers relative to non-carriers (Wishart et al., 2006) . Therefore, we applied PVC to PET images and also analyzed the effects of PVC. In this approach (MullerGartner et al., 1992) , binary mask images of GM and WM were smoothed to the system resolution (~6mm). For each dynamic PET frame, GM voxels were corrected for spill-in and spill-out of activity, assuming activity in CSF was zero and WM activity was uniform and was estimated from each image time frame.
Tracer Kinetic Modeling-Parametric images of BP ND (the ratio at equilibrium of
specifically bound radioligand to that of nondisplaceable radioligand in tissue (Innis et al.,
2007)) were generated using SRTM2 (Wu and Carson, 2002) using whole cerebellum as reference region for both uncorrected and partial volume corrected PET scans. BP ND was calculated so that a value of 0 reflects no specific binding, i.e., tracer uptake no greater than that in the reference region. This is directly related to the distribution volume ratio (DVR) reported
by other investigators (Reiman et al., 2009) , in that DVR=BP ND +1. BP ND images were created from both original, uncorrected data, and from partial-volume corrected image data. Three sets of BPND values were extracted: i) uncorrected BPND from the full AAL region, ii) uncorrected BPND from the AAL regions masked to only include GM voxels, and iii) PVC-BPND images, again with GM masking. In secondary analyses, we investigated the effect of PVC on measurement of Aβ binding. Unless otherwise noted, BP ND refers to the calculation using PVC images.
Statistical analyses
Differences among genotype groups were assessed using ANOVA for continuous variables and The association between Aβ burden and cortical GM fraction within the mean cortical ROI was assessed using a general linear model with mean cortical BP ND as the main explanatory variable and age and sex as covariates. For the association between Aβ burden and episodic memory performance, an episodic memory score was calculated (by averaging the z-scores for California M A N U S C R I P T 
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Results
Participant characteristics
The final study sample consisted of 45 cognitively normal FDRs who were enrolled in three APOE genotype groups: ε3ε3 (n=15), ε3ε4 (n=15), and ε4ε4 (n=15). Table 1 demographics and clinical characteristics of each group. As they were individually matched for age and sex, the APOE groups did not differ with respect to these variables. In addition, they did not differ in education, WRAT-3 Reading subtest standard score as an estimate of premorbid intelligence, MMSE, full scale IQ score, or GDS score.
Association between APOE Genotype and Cortical Aβ Burden (BP ND )
As depicted in Figure 1 , APOE ε4ε4 participants had significantly higher mean cortical BP ND (0.455) than those with ε3ε3 (0.187) (p<0.001), and ε3ε4 participants (0.346) were marginally higher than those with ε3ε3 (p=0.125), but ε4ε4 and ε3ε4 groups did not differ (p = 0.317 
Association between Cortical Aβ Burden (BP ND ) and Cortical Gray Matter Fraction
The unadjusted association between mean cortical BP ND and cortical GM fraction values within the mean cortical ROI in the overall sample is displayed in Figure 2A by a linear regression line and its 95% confidence interval. Mean cortical BP ND was inversely associated with GM fraction (regression coefficient = -0.046, p = 0.017) in a general linear model with adjustments for age and sex covariates. Post hoc analysis showed that this association was also present prior to PVC for GM masked mean cortical BP ND (regression coefficient = -0.046, p = 0.048, Figure 2C ).
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Association between Cortical Aβ Burden (BP ND ) and Episodic Memory Performance
The unadjusted association between BP ND and episodic memory performance values within the mean cortical ROI in the overall sample is displayed in Figure 2B by a linear regression line and its 95% confidence interval. There was no statistically significant association between mean cortical BP ND and episodic memory performance (regression coefficient = -0.317, p = 0.558) in a general linear model with adjustments for age and sex. Post hoc analysis showed that this association was also non-significant prior to PVC for GM masked mean cortical BP ND (regression coefficient = 0.127, p = 0.846, Figure 2D ).
Exploratory analysis was performed using the larger neuropsychological battery. APOE genotype was not associated with any of the neuropsychological test performance measures (Supplementary Table 2 ). In addition, there were no significant correlations between any neuropsychological test and mean cortical Aβ burden (BP ND ) in the overall sample (Supplementary Table 3 ).
Effect of Partial Volume Correction on BP ND
As expected, PVC tended to increase values of BP ND in the overall participant sample (N=45). by PVC (from uncorrected to PVC-corrected) was highly inversely associated with the cortical GM fraction (Spearman r = -0.46, p < 0.002). I.e., uncorrected analyses may underestimate Aβ burden to a greater extent in individuals with lower cortical GM fraction. Although APOE ε4
allele number is associated with increased cortical amyloid even prior to PVC, PVC improved the goodness of fit (R 2 ) for the overall model (Table 2 ). In addition, the association between cortical GM fraction and cortical Aβ burden is significantly greater when PVC is performed compared with GM mask correction alone (Williams t-score = 2.15, p = 0.04) or with no correction (Williams t-score = 3.04, p = 0.004).
Discussion
We studied cognitively normal middle-aged individuals with a first-degree family history of AD and varying APOE risk to investigate the relationship between Aβ deposition, GM fraction, and neuropsychological test performance in this unique population. APOE ε4ε4 participants demonstrated significantly higher mean cortical Aβ burden (PVC BP ND ) than ε3ε3 participants, with ε3ε4 marginally higher than ε3ε3 participants. In the overall sample, Aβ burden was inversely associated with GM fraction within the mean cortical ROI. Reported results show no statistically significant association between mean cortical Aβ burden and episodic memory performance. PVC increased values of BP ND and led to a statistically significant increase in the association between cortical Aβ burden and GM fraction.
Comparison with In Vivo Imaging Studies
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Mecca, A.P. et al p. 14 Our results corroborate and extend observations by Reiman et al (Reiman et al., 2009 ), but with a somewhat reduced APOE ε4 effect on Aβ deposition in this younger sample (mean age 59 vs. 64). Our findings are also consistent with those of Johnson et al. (Johnson et al., 2014) and demonstrate that in high-risk individuals, considerable Aβ deposition begins by the early 50s, and earlier than has generally been reported in large series of cognitively normal participants Rowe et al., 2010) .
Neuropsychological test results confirmed the full cognitive "normality" of many at risk participants with considerable fibrillar Aβ burden. Mean cortical BP ND was unrelated to an index of episodic memory performance for the pooled sample of 45 participants. These results agree with those of Johnson et al. (Johnson et al., 2014) , who also observed no relationship between Aβ status and any of several cognitive measures in an at-risk middle aged sample (mean age 60.1 years). In other Aβ imaging studies of cognitively normal elderly individuals (generally > age 65), Aβ binding has been shown to be associated with cognitive performance in some (Hedden et al., 2012; Rentz et al., 2010; Rodrigue et al., 2012; Sperling et al., 2013) , but not all (Harrington et al., 2013 ) previous studies. In some studies, an association has been observed with episodic memory only in females (Pike et al., 2011) or in APOE ε4 carriers (Lim et al., 2013a) .
Our finding of an inverse association between Aβ deposition and GM fraction within the Aβ susceptible brain regions-in the absence of a cognitive association-is somewhat unexpected.
Previous studies have demonstrated that cognitively normal elderly individuals with brain Aβ accumulation demonstrate subtle cortical thinning (Dickerson et al., 2009) , greater rates of cortical and hippocampal atrophy (Andrews et al., 2013; Chetelat et al., 2012; Schott et al., M A N U S C R I P T Mecca, A.P. et al p. 15 2010) , and disruption of functional connectivity (Hedden et al., 2009; Mormino et al., 2011; Sheline et al., 2010) . However, these studies generally involve the older age range (>65 years), in which Aβ burden has also been associated with cognitive function. Our results differ from those of Johnson et al. (Johnson et al., 2014) , who observed no association between Aβ status and GM volume in subjects of similar age. This divergence may relate to different methods of evaluating gray matter (GM fraction within the Aβ susceptible ROIs versus voxel based morphometry) or our analysis of Aβ deposition as a continuous rather than categorical variable.
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A major difference between our subject sample and those of most of the other referenced studies is that our participants are significantly younger and largely non-overlapping in age with other samples. They may simply fall at an earlier stage of preclinical disease without "subtle cognitive decline" (Sperling et al., 2011) . Alternatively, they may exhibit lesser aging effects in comparison to the older participants in other studies. Age-related atrophy occurs partly in ADspecific brain regions and may have additive effects with AD-related neurodegeneration (Bakkour et al., 2013) . Thus, our middle-aged subjects may have greater "brain reserve" compared to older preclinical samples and may not manifest cognitive effects of Aβ deposition and early neurodegeneration. The preclinical stage of AD has been theorized to include substages of Aβ deposition with and without neuronal damage and subtle cognitive symptoms (Sperling et al., 2011) . Thus our findings are fully consistent with this theoretical model. They suggest that future prevention studies may benefit from intervention at a younger age and an earlier preclinical stage than the current A4 study (Sperling et al., 2014) . Enrichment of samples through family history and APOE genotyping will likely be necessary.
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Implications for Early Intervention
Our finding that Aβ burden is inversely associated with GM fraction prior to an association with any cognitive measures has particular implications for future prevention strategies. A limitation of the present study is its cross-sectional design, which cannot fully establish the temporal relationship implicated in the association of Aβ burden with GM losses. Longitudinal studies that span the emergence of Aβ pathogenesis may be necessary to establish whether the early steps in this process are already associated with GM reductions and other markers of neuronal injury.
However, the definition of this stage will be critical to determine the optimal period for intervention strategies. A broad range of potential interventions-including anti-Aβ strategies or attempts to repair structural defects of APOE ε4 (Mahley and Huang, 2012)-should ultimately be implemented prior to earliest neurodegeneration. It presently remains unclear whether an early stage of Aβ pathogenesis fully precedes neuronal injury and thus whether detection of fibrillar Aβ deposition in the brain by a screening test is a sufficient condition for identifying candidates for early intervention studies.
Importance of Partial Volume Correction
Finally, our results underscore the importance of PVC for Aβ PET imaging, even in the preclinical stages of AD. The fact that Aβ burden is inversely associated with GM fraction at a preclinical stage inherently entails that uncorrected analyses will underestimate Aβ burden in the very individuals with the greatest burden. Indeed, our additional analyses confirm that the increase in mean cortical BP ND yielded by PVC is highly inversely associated with the fraction of M A N U S C R I P T
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GM within the mean cortical ROI. Additional support for performing PVC in the present study is provided by the improved overall model fit of BP ND values vs. APOE genotype (Table 2) , i.e., PVC enlarges group differences in Aβ burden. Although PVC has not been widely employed in
Aβ PET imaging-and has been essentially absent from preclinical investigations-these results highlight the advantages of correcting for partial volume effects when performing Aβ imaging in the preclinical stages.
Recently, interest has mounted in performing PVC for Aβ PET (Gonzalez-Escamilla et al., 2017; Shidahara et al., 2017) . The optimal method of PVC for PET imaging remains a topic of investigation (For review, see (Erlandsson et al., 2012) ), with alternatives including region-based methods such as the regional spread function (RSF) method (Rousset et al., 2008) , as well as voxel-based methods such as the Muller-Gartner algorithm used here. The selection of a PVC method is based on several factors, including the system point-spread function and its spatial variation, assumptions about uniformity of tracer uptake within regions, and the accuracy of registrations and segmentations. As an example, Su et al. (Su et al., 2015) compared 2 PVC methods, the 2-compartment image-based method (Meltzer et al., 1990 ) which corrects for GM loss but not for spill-in between WM and GM, and RSF, and concluded that RSF performed better. However, this conclusion was based in part on a simulation study, for which the validity may be limited to the chosen simulation conditions. Here, we used the Muller-Gartner method, Mask images of gray and white matter were smoothed to the system resolution (~6mm). For each dynamic PET frame, GM voxels were corrected for spill-in and spill-out of activity, assuming M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT Mecca, A.P. et al p. 30 activity in CSF was zero and WM activity was uniform and was estimated from the centrum semiovale. Finally, SRTM2 was re-applied to the PVC-images to produce PVC-corrected BP ND values. In the resulting PVC images, values in white matter voxels are not corrected. 
